ConductScience.org, home

Paper28299619

Double- and Triple-Positive Tumor Markers Predict Early Recurrence and Poor Survival in Patients with Hepatocellular Carcinoma within the Milan Criteria and Child-Pugh Class A.

Ryu T and 6 others. J Gastrointest Surg, 2017. Cited by 22 papers, by iCite.

Cite this record

ConductScience Library. Double- and Triple-Positive Tumor Markers Predict Early Recurrence and Poor Survival in Patients with Hepatocellular Carcinoma within the Milan Criteria and Child-Pugh Class A. Papers, record 28299619. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28299619

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Double- and Triple-Positive Tumor Markers Predict Early Recurrence and Poor Survival in Patients with Hepatocellular Carcinoma within the Milan Criteria and Child-Pugh Class A.
PubMed
Journal
J Gastrointest Surg
PubMed
Year
2017
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
22
iCite
Relative citation ratio, by iCite
0.89
iCite
Revised in PubMed
2024-02-13
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Ryu TTomokihttps://orcid.org/0000-0001-6610-0184
2Takami YYuko
3Wada YYoshiyuki
4Tateishi MMasaki
5Matsushima HHajime
6Mikagi KKazuhiro
7Saitsu HHideki

Source PubMed

Download CSV of authors

Topics21

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Biomarkers, TumorMajor topic
Carcinoma, HepatocellularMajor topic
HepatectomyMajor topic
Liver NeoplasmsMajor topic
Neoplasm Recurrence, LocalMajor topic
Adult
Aged
Aged, 80 and over
Biomarkers
Female
Follow-Up Studies
Humans
Male
Middle Aged
Plant Lectins
Prognosis
Protein Precursors
Prothrombin
Retrospective Studies
Survival Analysis
alpha-Fetoproteins

Source PubMed

Download CSV of topics

References25

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
121606837Triple positive tumor markers for hepatocellular carcinoma are useful predictors of poor survival.Ann Surg2011https://conductscience.org/library/papers/21606837PubMed
211169939Des-gamma-carboxy prothrombin as a useful predisposing factor for the development of portal venous invasion in patients with hepatocellular carcinoma: a prospective analysis of 227 patients.Cancer2001https://conductscience.org/library/papers/11169939PubMed
39794907Early hepatocellular carcinoma as an entity with a high rate of surgical cure.Hepatology1998https://conductscience.org/library/papers/9794907PubMed
415690326Percutaneous radiofrequency ablation for hepatocellular carcinoma. An analysis of 1000 cases.Cancer2005https://conductscience.org/library/papers/15690326PubMed
516542289Diagnostic and prognostic role of alpha-fetoprotein in hepatocellular carcinoma: both or neither?Am J Gastroenterol2006https://conductscience.org/library/papers/16542289PubMed
620711614Alpha-fetoprotein above normal levels as a risk factor for the development of hepatocellular carcinoma in patients infected with hepatitis C virus.J Gastroenterol2011https://conductscience.org/library/papers/20711614PubMed
718087193Microwave ablation of hepatocellular carcinoma.Oncology2007https://conductscience.org/library/papers/18087193PubMed
816431313Prognostic significance of simultaneous measurement of three tumor markers in patients with hepatocellular carcinoma.Clin Gastroenterol Hepatol2006https://conductscience.org/library/papers/16431313PubMed
919259739Recurrence patterns after hepatectomy of hepatocellular carcinoma: implication of Milan criteria utilization.Ann Surg Oncol2009https://conductscience.org/library/papers/19259739PubMed
1016682732Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world.J Clin Oncol2006https://conductscience.org/library/papers/16682732PubMed
119927159Clinical utility of Lens culinaris agglutinin-reactive alpha-fetoprotein in small hepatocellular carcinoma: special reference to imaging diagnosis.J Hepatol1999https://conductscience.org/library/papers/9927159PubMed
1227577937Simultaneous microwave coagulo-necrotic therapy (MCN) and laparoscopic splenectomy for the treatment of hepatocellular carcinoma with cirrhotic hypersplenism.Surg Today2017https://conductscience.org/library/papers/27577937PubMed
1326955286Efficacy of surgical treatment using microwave coagulo-necrotic therapy for unresectable multiple colorectal liver metastases.Onco Targets Ther2016https://conductscience.org/library/papers/26955286PubMed
1410898182Seven hundred forty-seven hepatectomies in the 1990s: an update to evaluate the actual risk of liver resection.J Am Coll Surg2000https://conductscience.org/library/papers/10898182PubMed
158983610Recurrence of hepatocellular carcinoma after surgery.Br J Surg1996https://conductscience.org/library/papers/8983610PubMed
1624245496Triple positive tumor markers predict recurrence and survival in early stage hepatocellular carcinoma.Hepatol Res2014https://conductscience.org/library/papers/24245496PubMed
174541913Transection of the oesophagus for bleeding oesophageal varices.Br J Surg1973https://conductscience.org/library/papers/4541913PubMed
1821278701The incidence of hepatocellular carcinoma associated with hepatitis C infection decreased in Kyushu area.Med Sci Monit2011https://conductscience.org/library/papers/21278701PubMed
1920582515Impact of the preoperative des-gamma-carboxy prothrombin level on prognosis after hepatectomy for hepatocellular carcinoma meeting the Milan criteria.Surg Today2010https://conductscience.org/library/papers/20582515PubMed
208546582Results of 280 liver resections for hepatocellular carcinoma.Arch Surg1996https://conductscience.org/library/papers/8546582PubMed

See all 25 referencesDownload CSV of references

Cited by16

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 22 citations.

PMIDTitleJournalYearIn PapersSource
41249657Improving surgical treatments for hepatocellular carcinoma.Nat Rev Gastroenterol Hepatol2026https://conductscience.org/library/papers/41249657PubMed
39330520
Liquid Chromatography/Tandem Mass Spectrometry-Based Simultaneous Analysis of 32 Bile Acids in Plasma and Conventional Biomarker-Integrated Diagnostic Screening Model Development for Hepatocellular Carcinoma.
Metabolites2024https://conductscience.org/library/papers/39330520PubMed
38149643Ablative and non-surgical therapies for early and very early hepatocellular carcinoma: a systematic review and network meta-analysis.Health Technol Assess2023https://conductscience.org/library/papers/38149643PubMed
37686624Usefulness of Tumor Marker Score for Predicting the Prognosis of Hepatocellular Carcinoma Patients Treated with Atezolizumab Plus Bevacizumab: A Multicenter Retrospective Study.Cancers (Basel)2023https://conductscience.org/library/papers/37686624PubMed
35271670Clinical evaluation of Elecsys PIVKA-II for patients with advanced hepatocellular carcinoma.PLoS One2022https://conductscience.org/library/papers/35271670PubMed
34638251Baseline Alpha-Fetoprotein, Alpha-Fetoprotein-L3, and Des-Gamma-Carboxy Prothrombin Biomarker Status in Bridge to Liver Transplant Outcomes for Hepatocellular Carcinoma.Cancers (Basel)2021https://conductscience.org/library/papers/34638251PubMed
34506026Prognostic Significance of Preoperative Tumor Markers in Pseudomyxoma Peritonei from Low-Grade Appendiceal Mucinous Neoplasm: a Study from the US HIPEC Collaborative.J Gastrointest Surg2022https://conductscience.org/library/papers/34506026PubMed
34488769Iron-sulphur cluster biogenesis factor LYRM4 is a novel prognostic biomarker associated with immune infiltrates in hepatocellular carcinoma.Cancer Cell Int2021https://conductscience.org/library/papers/34488769PubMed
34377560The Role of the MCTS1 and DENR Proteins in Regulating the Mechanisms Associated with Malignant Cell Transformation.Acta Naturae2021https://conductscience.org/library/papers/34377560PubMed
33531992A Practical Model is Equivalent to the BALAD or BALAD-2 Score in Predicting Long-term Survival after Hepatectomy in Chinese Patients with Hepatocellular Carcinoma.J Cancer2021https://conductscience.org/library/papers/33531992PubMed
32998218Prognostic Role of Serum Cytokeratin-19 Fragment (CYFRA 21-1) in Patients with Hepatocellular Carcinoma.Cancers (Basel)2020https://conductscience.org/library/papers/32998218PubMed
31541423APASL HCV guidelines of virus-eradicated patients by DAA on how to monitor HCC occurrence and HBV reactivation.Hepatol Int2019https://conductscience.org/library/papers/31541423PubMed
31231700Transplantation versus liver resection in patients with hepatocellular carcinoma.Transl Gastroenterol Hepatol2019https://conductscience.org/library/papers/31231700PubMed
30788712A Clinical Scoring System for Predicting Microvascular Invasion in Patients with Hepatocellular Carcinoma Within the Milan Criteria.J Gastrointest Surg2019https://conductscience.org/library/papers/30788712PubMed
30655749High expression of density-regulated re-initiation and release factor drives tumourigenesis and affects clinical outcome.Oncol Lett2019https://conductscience.org/library/papers/30655749PubMed
29736665Prognosis of Hepatocellular Carcinoma Patients Who Achieved Long-Term Recurrence-Free Survival After Curative Therapy: Impact of the ALBI Grade.J Gastrointest Surg2018https://conductscience.org/library/papers/29736665PubMed

Download CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ACE1636PubTator's text mininghttps://conductscience.org/library/genes/1636NCBI Gene
AFP174PubTator's text mininghttps://conductscience.org/library/genes/174NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/28299619

GET https://conductscience.org/api/papers/v1/28299619/references?page=2